BUHLMANN Quantum Blue® TDM Tutorial

View this demonstration of quantitative trough level measurement for TDM using the Quantum Blue® TDM rapid test technology.  

Quantum Blue® Adalimumab: 
Health Canada License: 101776

Quantum Blue® Infliximab:
Health Canada License: 98838

US: (The Quantum Blue® tests are for Research Use Only. Not for use in diagnostic procedures.)

Contact BUHLMANN Today!

Contact us & learn more about our Quantum Blue® rapid tests & Quantum Blue® Reader.

The Quantum Blue® rapid test combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody), with full quantification by means of a small, telephone sized reading device. The Quantum Blue® Reader analyzes the signal intensity from the test and control line to give a quantitative value.